The global tacrolimus ointment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment is a drug that is applied to the skin for the treatment of atopic dermatitis (eczema). Further, atopic dermatitis is a chronic (long-lasting) disease of the skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. Moreover, tacrolimus ointment is available in two strengths such as 0.03% and 0.1%. 0.03% is suitable for use by children and 0.1% is suitable for use by adults.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/tacrolimus-ointment-market
Some major players in the market include Astellas Pharma Inc., GlaxoSmithKline plc, and Glenmark Pharmaceuticals Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2020, Glenmark Pharma has announced that the company has received final approval from the US health regulator Food and Drug Administration (FDA) for Tacrolimus Ointment, 0.1%, the generic version of Protopic Ointment, 0.1%, of Leo Pharma AS. In addition, according to IQVIATM sales data for the 12-month period ending February 2018, the Protopic Ointment, 0.1% market achieved annual sales of approximately $109.0 million.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Product Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Astellas Pharma Inc., GlaxoSmithKline plc, and Glenmark Pharmaceuticals Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Tacrolimus Ointment Market Report by Segment
By Product Type
- Ointment 0.1
- Ointment 0.03
By Application
- Adults
- Kids
A full report of Tacrolimus Ointment Market is available at: https://www.omrglobal.com/industry-reports/tacrolimus-ointment-market
Tacrolimus Ointment Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Astellas Pharma Inc.
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
